Cortechs.ai and Microsoft have integrated quantitative imaging and AI-driven biomarkers into PowerScribe One, automating volumetric measurements and report generation for neurodegenerative disease, neuro-oncology, traumatic brain injury, and prostate assessment. This workflow automation reduces manual entry and accelerates clinical decision-making in radiology.
Key Points
- FDA-cleared quantitative imaging integrated into PowerScribe One reporting
- Automated volumetrics and biomarkers reduce manual data entry burden
- Deployment available for neurodegenerative, oncology, and prostate imaging workflows
Longevity Analysis
Automating imaging biomarker extraction and report generation removes a significant source of clinical workflow friction that delays diagnosis and intervention in conditions directly affecting neurological health, cancer progression, and tissue degeneration. By embedding quantitative measurements directly into reporting systems, clinicians gain faster access to objective biomarkers that reflect the true state of organ integrity and function—critical inputs for early detection and monitoring of age-related disease. This systemic efficiency gain matters because diagnostic delays compound physiological damage; acceleration of signal interpretation directly supports earlier intervention windows.
Original published by LT Wire.